Lungs News and Research

RSS

New Lifescript Asthma Health Center for women and children

Lifescript.com, a women's health and wellness website headquartered in Mission Viejo, Calif., has launched a new online Asthma Health Center designed to help women and children diagnose and manage asthma symptoms.

21 Jun 2012

ECC calls on policy makers across Europe to reduce burden of COPD

As leading figures in respiratory health from across the globe gather in Birmingham for the COPD8 conference ahead of World Spirometry Day, the European COPD Coalition (ECC) is calling on policy makers across Europe to recognise that chronic diseases such as COPD, present as great a threat as the global financial crisis, and is urging collective action.

20 Jun 2012

Large proportions of European coronary patients do not benefit from cardiac rehabilitation services

Large proportions of European coronary patients are not benefitting from cardiac rehabilitation services, according to results of the third EUROASPIRE survey published today in the European Journal of Preventive Cardiology.

20 Jun 2012

Viewpoints: For Fla. small business owner, loss of health law would be 'real blow;' Effort to silence Mich. legislators backfires

Running a small business with four employees, I've got a lot hanging in the balance as the Supreme Court deliberates on the healthcare law. The legal challenge to the law was launched here in Florida with a small business lobby group as a plaintiff in the case. But if you're thinking that means small business people like me want to see the law rolled back, think again. The simple fact is, the healthcare law is saving our business serious money and saving our healthcare benefits.

20 Jun 2012

AstraZeneca, Rigel enter global license agreement for R256 inhaled JAK inhibitor to treat chronic asthma

AstraZeneca and Rigel Pharmaceuticals Inc. today announced an exclusive worldwide license agreement for the global development and commercialization of R256, Rigel's inhaled JAK inhibitor shown to inhibit IL-13 and IL-4 signalling, which is being investigated as a treatment for moderate to severe chronic asthma. In preclinical research, R256 has been shown to reduce airway inflammation and improve lung function.

19 Jun 2012

International Lung Disease conference welcomed to Birmingham by Minister of State for Health

The Minister of State for Health, Simon Burns MPs, is welcoming the major international lung disease conference COPD8 to Birmingham on June 20th as clinicians, researchers and politicians turn their minds to the growing issue of COPD (Chronic Obstructive Pulmonary Disease) for healthcare systems and wider society.

19 Jun 2012

Skin disease shares common inflammatory pathway with metabolic disorder

Psoriasis is an independent risk for Type 2 Diabetes, according to a new study by researchers with the Perelman School of Medicine at the University of Pennsylvania, with the greatest risk seen in patients with severe psoriasis.

19 Jun 2012

ALung completes pilot study of Hemolung RAS in COPD patients

ALung Technologies, Inc., a leading developer of innovative lung assist devices, presented an analysis of its recent clinical trial of the Hemolung Respiratory Assist System (RAS) in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD).

19 Jun 2012

Pediatric treatment regime for ALL patients improves chances of long-term survival

Acute lymphoblastic leukemia (ALL), usually found in pediatric patients, is far more rare and deadly in adolescent and adult patients. According to the National Marrow Donor Program, child ALL patients have a higher than 80 percent remission rate, while the recovery rate for adults stands at only 40 percent.

18 Jun 2012

Multi-institutional research uncovers new mechanism for treatment of lung cancer

A multi-institutional research study has uncovered a new mechanism that may lead to unique treatments for lung cancer, one of the leading causes of death worldwide.

18 Jun 2012

Infinity voluntarily stops saridegib Phase 2 trial for chondrosarcoma

Infinity Pharmaceuticals, Inc. today announced interim data from its Phase 2, double-blind, randomized, placebo-controlled study of saridegib (IPI-926) in patients with metastatic or locally advanced, inoperable chondrosarcoma. The primary endpoint of the Phase 2 study was progression-free survival.

18 Jun 2012

Agility MLC's new design provides better dose sculpting capabilities

Requiring only a quick upgrade to their existing Elekta Synergy linear accelerator, physicians at SALK and Paracelsus Medical University began using the new Agility 160-leaf multileaf collimator (MLC), treating 33 patients on its first day. In its first month of Agility use, the center now treats 50 patients per day, comprising about 700 individual treatment sessions that have benefited from this breakthrough in cancer care.

From Elekta 18 Jun 2012

Stereotactic ablative radiotherapy benefits stage I non-small cell lung cancer patients

Until recently, many elderly patients with stage I non-small cell lung cancer were left untreated because treatment may not improve their quality of life. However, stereotactic ablative radiotherapy (SABR) has become one of the standards of treatment for these patients. The outpatient treatment given over a two-week period allows frail patients to undergo the treatment.

16 Jun 2012

Surgeon specialty, hospital volume important factors in patient outcomes

In other studies, outcomes of specific surgeries has been shown to improve when performed at high-volume centralized centers. Researchers from the Netherlands Cancer Institute wanted to understand if patients undergoing lung cancer resections would benefit from having their procedures performed in a high-volume specialized center.

16 Jun 2012

Chemotherapy improves survival for patients with SCLC and LCNEC

Research presented in the July 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, concluded that patients with limited large cell neuroendocrine tumors or with limited stage small-cell lung cancer who were treated with perioperative chemotherapy and surgery had better overall survival outcomes than patients treated with surgery alone.

16 Jun 2012

Roundup: Iowa redesign of mental health services raises concerns; Mich. lawmakers opposed to abortion restrictions are 'silenced'

State leaders hope their mental health redesign will bring better services to (rural areas of Iowa), but many front-line administrators doubt they'll see significant improvements soon. In fact, some worry that services could erode over the next year as money and some financial responsibilities are shifted from the counties to the state. Some long-term improvements are possible, they say, but cash likely will run short in the next few months.

15 Jun 2012

Life-saving kidney transplants now available for older patients

In the past, a patient 55 or older had little or no chance of receiving a life-saving kidney transplant. But improvements in medicine have many doctors re-evaluating older patients who need a new organ.

15 Jun 2012

Antioxidant rhSOD reduces risk of blindness in extremely low gestational age newborns

Retinopathy of prematurity (ROP) is the second most common cause of childhood blindness in the United States, occurring in half of premature infants born earlier than or at 28 weeks gestational age. The condition is caused by abnormal blood vessel development in the retina of the eye. ROP risk increases with decreasing gestational age.

15 Jun 2012

Sanovas receives U.S. patent allowance for microsurgical lung cancer technology

Sanovas, Inc., a medical technology company focused on developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for its first patent relating to systems and methods for the removal of unwanted biological material, such as tissue growths and tumors, in hard-to-reach bodily cavities.

15 Jun 2012

High-efficiency oxygen inhaler from Dehaier

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that the Company has co-developed its "High-Efficiency Oxygen Inhaler" with Dr. Ding Jianzhang of Beijing Haidian Hospital, which is expected to begin selling in the third quarter of 2012 in mainland China.

15 Jun 2012

Lungs News and Research

New Lifescript Asthma Health Center for women and children

ECC calls on policy makers across Europe to reduce burden of COPD

Large proportions of European coronary patients do not benefit from cardiac rehabilitation services

Viewpoints: For Fla. small business owner, loss of health law would be 'real blow;' Effort to silence Mich. legislators backfires

AstraZeneca, Rigel enter global license agreement for R256 inhaled JAK inhibitor to treat chronic asthma

International Lung Disease conference welcomed to Birmingham by Minister of State for Health

Skin disease shares common inflammatory pathway with metabolic disorder

ALung completes pilot study of Hemolung RAS in COPD patients

Pediatric treatment regime for ALL patients improves chances of long-term survival

Multi-institutional research uncovers new mechanism for treatment of lung cancer

Infinity voluntarily stops saridegib Phase 2 trial for chondrosarcoma

Agility MLC's new design provides better dose sculpting capabilities

Stereotactic ablative radiotherapy benefits stage I non-small cell lung cancer patients

Surgeon specialty, hospital volume important factors in patient outcomes

Chemotherapy improves survival for patients with SCLC and LCNEC

Roundup: Iowa redesign of mental health services raises concerns; Mich. lawmakers opposed to abortion restrictions are 'silenced'

Life-saving kidney transplants now available for older patients

Antioxidant rhSOD reduces risk of blindness in extremely low gestational age newborns

Sanovas receives U.S. patent allowance for microsurgical lung cancer technology

High-efficiency oxygen inhaler from Dehaier

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News